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The aim of this paper was to determine whether the interaction between IGF, IGFBP, and VN modulates the functions of porcine
EOE cells. Enamel organs from 6-month-old porcine third molars were dissociated into single epithelial cells and subcultured
on culture dishes pretreated with VN, IGF-I, and IGFBP-3 (IGF-IGFBP-VN complex). The subcultured EOE cells retained their
capacity for ameloblast-related gene expression, as shown by semiquantitative reverse transcription-polymerase chain reaction.
Amelogenin expression was detected in the subcultured EOE cells by immunostaining. The subcultured EOE cells were then
seeded onto collagen sponge scaﬀolds in combination with fresh dental mesenchymal cells and transplanted into athymic rats.
After 4 weeks, enamel-dentin-like complex structures were present in the implanted constructs. These results show that EOE cells
cultured on IGF-IGFBP-VN complex diﬀerentiated into ameloblasts-like cells that were able to secrete amelogenin proteins and
form enamel-like tissues in vivo. Functional assays demonstrated that the IGF/IGFBP/VN complex signiﬁcantly enhanced porcine
EOE cell proliferation and tissue forming capacity for enamel. This is the ﬁrst study to demonstrate a functional role of the IGF-
IGFBP-VN complex in EOE cells. This application of the subculturing technique provides a foundation for further tooth-tissue
engineering and for improving our understanding of ameloblast biology.
1.Introduction
A frequent dental disease is dental caries which is a speciﬁc
infectious disease that results in localized dissolution and
destruction of the calciﬁed enamel and dentin in teeth.
However, enamel cannot regenerate by itself, because the
layer of ameloblasts that forms the enamel degenerates after
the tooth crown is completed. Thus dentistry has formulated
artiﬁcial materials that mimic the hardness of enamel to
repair enamel loss, but this may not be the most appropriate
therapy. Therefore, the development of a novel approach to
engineer natural enamel to repair enamel loss is strongly
desired.
The growth of enamel is a highly complex process that is
tightly regulated through a number of control mechanisms.
Numerous growth factors involved in enamel development
have been shown to interact with components of the
extracellular matrix (ECM). Growth factors can regulate
proliferation, determination, and diﬀerentiation of enamel-
lineage cell phenotypes. The interaction between the ECM
and growth factors is believed to be an important modulator
of enamel development. However, many of the mechanisms
behind these interactions remain unclear.
The insulin-like growth factor (IGF) family consists of
two growth factors, IGF-I and IGF-II, which are mitogenic
peptide growth factors. They are involved in a diverse2 International Journal of Dentistry
range of biological functions including development [1],
cell proliferation and diﬀerentiation [2, 3], and DNA
synthesis [4, 5], as well as insulin-like eﬀects including
an involvement in fat metabolism [1]. The IGF family is
tightly regulated by two IGF receptors (IGF-IR and IGF-
IIR), six IGF binding proteins (IGFBP-1 to IGFBP-6), and
multiple IGFBP proteases [1, 6, 7]. Both IGF-I and IGF-II
and their corresponding receptors are expressed throughout
amelogenesis in rat incisors [8]. The IGF family is associated
with the secretion of enamel-related proteins in rodent teeth
[9], and furthermore, IGF-I stimulates cell proliferation in
Hertwig’s epithelial root sheath in the mouse molar [10].
Vitronectin (VN) is a multifunctional 75kDa glycopro-
tein that is highly abundant in the blood and numerous
tissues and forms a major component of the ECM [11].
VN plays an important role in diverse cellular processes,
including cell migration, cell attachment, cell spreading,
and hemostasis, that are mediated via αv integrins (αvβ3
and αvβ5 receptors which recognize an Arg-Gly-Asp [RGD]
sequence) adjacent to the protein’s N-terminus [12–15]. VN
is also involved in the immune defense system through
its interaction with the terminal complex of complement
[16]. It has been suggested that VN binds to growth factors
including epidermal growth factor and ﬁbroblast growth
factor [17, 18], hepatocyte growth factor, IGF-II [19], and
I G F - I( v i aI G F B P s )[ 20]. The functional signiﬁcance of these
interactions has been conﬁrmed through observation of in
vitro cellular responses in culture plates pretreated with VN
and IGF [21, 22], and the ability of VN to modify IGF action
in smooth muscle cells has also been demonstrated [12].
Subsequent studies have revealed that IGFBP-3, enhances
IGF-I binding to VN by forming a heterotrimeric complex
comprising of IGF-1, IGFBP-3 and VN (IGF-IGFBP-VN)
[20, 23, 24] and the complex results in enhanced functional
responses [20, 21]. However, there have been no reports of
this IGF-IGFBP-VN complex in the enamel-lineage cells, the
enamel organ-derived epithelial (EOE) cells.
This study therefore examined whether the approach
of prebinding IGF and IGFBP to VN-coated culture dishes
would be eﬀective in culturing EOE cells in order to produce
enamel by tissue engineering methods. This strategy was
adopted in an attempt to more accurately reﬂect the in
vivo cellular environment (rather than an eﬀect of IGF
and IGFBP in solution) in which growth factors “captured”
by ECM proteins participate in coordinated matricellular
signaling [25]. The environment signiﬁcantly enhanced cell
proliferation and maintained the phenotype of the primary
EOE cells. In addition, EOE cells cultured on IGF-IGFBP-
VN-coated dishes, in combination with primary dental pulp
cells, were capable of growing new enamel-like tissues. This
studyisoneoftheﬁrststudiestodemonstratethecriticalrole
of IGF-I, IGFBP-3, and VN on EOE cells.
2.MaterialsandMethods
2.1. Isolation and Subculture of Porcine EOE Cells. EOE
c e l l sw e r ep r e p a r e da sp r e v i o u s l yd e s c r i b e d[ 26, 27]. Brieﬂy,
impacted third molars were harvested from the mandibles of
6-month-old pigs. After hard tissues were disconnected from
the tooth, the enamel organ was separated from the dental
pulp by treatment with dispase II (Goudou Syuzei, Tokyo,
Japan)andthenmechanicallyisolated.Mincedenamelorgan
was treated with collagenase (Wako, Osaka, Japan) in Hank’s
balanced salt solution (Invitrogen, Life Technologies, NY).
The released cells were passed through a 70μm cell strainer
(Becton Dickinson & Co., Franklin Lakes, NJ) and were then
cultured in Dulbecco’s modiﬁed eagle medium (DMEM)
containing 10% fetal bovine serum (FBS; Invitrogen) under
10% CO2 i na i rf o r7d a y s .
A mixed cell population of EOE cells and dental follicle
cells were observed in primary culture. Then, to isolate the
epithelial cells from the mesenchymal cells, the medium
was replaced with LHC-9 medium (Bioﬂuids, Bethesda,
MD) without FBS after the cell populations reached con-
ﬂuence [26]. The cells were cultured under 10% CO2 for
2 weeks, during which time most of the contaminating
dental follicle cells disappeared, leaving only morpholog-
ically identiﬁable epithelial cells. The epithelial cells were
trypsinized and inoculated onto the speciﬁed culture dishes
(1 × 105 cells/cm2). Complete minimum essential medium
based on α-MEM (Invitrogen) supplemented with 5% FBS,
insulin (5.0μg/mL), transferrin (5μg/mL), triiodothyronine
(2 × 10
−10 M), cholera toxin (1 × 10
−10 M), hydrocortisone
(0.5μg/mL), epidermal growth factor (0.1μg/mL), penicillin
(1000 U/mL), streptomycin (1mg/mL), and amphotericin B
(2.5μg/mL) was applied to the subsequent subcultures. The
cultured cells were observed by phase-contrast microscopy
on indicated days.
2.2. Prebinding of IGF-I and IGFBP-3 to VN (IGF-IGFBP-
VN). To examine the eﬀect of IGF-IGFBP-VN on EOE
cells, culture plates were pretreated overnight with VN
(150ng/cm2; Tissue Therapies, Brisbane, Australia) prior to
the addition of growth factors including IGF-I (50ng/cm2;
Tissue Therapies) and IGFBP-3 (150ng/cm2; Tissue Thera-
pies), according to the protocol [19, 28], and each treatment
was usually performed overnight at 4◦C. All reagents were
prepared in serum-free medium. For comparison, either
polystyrene (PS) or collagen- type- I- (Col-I-) coated dishes
(Becton Dickinson & Co.) were used to evaluate cell growth
and diﬀerentiation.
2.3. Measurement of Cell Growth. The growth of 1st and
2nd passage EOE cells on IGF-IGFBP-VN-coated dishes was
examined in comparison with PS, and Col-I dishes. Subcul-
t u r e dE O Ec e l l sw e r ep l a t e da tad e n s i t yo f5× 103 cells/mL
into 6-well IGF-IGFBP-VN, PS and Col-I culture plates.
The EOE cells in each well were counted using a WST-8
kit (Cell-counting Kit-8; Dojindo Laboratories, Kumamoto,
Japan). The counting technique employed a tetrazolium
salt that produced a highly water-soluble formazan dye.
After 1 hour of incubation with the reagent according to
the manufacturer’s instructions, relative cell numbers were
determined by measuring the absorbance of light at a
wavelength of 450nm on days 1, 10, and 25 (Model 650
Microplatereader;Bio-RadLaboratories,Hercules,CA).The
experiment on cell growth was performed in triplicate.International Journal of Dentistry 3
Statistical analysis was performed using Mann-whitney
U test with Bonferroni’s correction. Data are presented as the
mean ± standard deviation for three separate experiments. A
signiﬁcant diﬀerence (P<0.05) between paired conditions is
indicated on Figures by an asterisk.
2.4.RNAPreparationandSemiquantitativeReverseTranscrip-
tion-Polymerase Chain Reaction (RT-PCR) Analysis. Total
cellular RNA was puriﬁed from primary cells in nonserum
culture medium for 10 days and subcultured cells at 10
days after ﬁrst passage from three samples, using TRI-
ZOL reagent (Invitrogen) according to the manufacturer’s
instructions. cDNA was synthesized from 1μgo ft o t a lR N A
using Superscript III RNase H- (Invitrogen). Synthesized
cDNA served as a template for subsequent polymerase chain
reaction (PCR) ampliﬁcation. PCR primers for amelogenin,
ameloblastin, enamelin, matrix-metalloprotease- (MMP-)
20, collagen type I, IGF-I, and IGF-I receptor are listed in
Table 1. Ampliﬁcation was performed in a PCR Thermal
Cycler SP (Takara, Tokyo, Japan) for 25–35 cycles according
to the following reaction proﬁle: 95◦C for 30s, 45–60◦Cf o r
30s,and72◦C for30s.Porcine β-actinprimer wasusedasan
internal standard.
2.5. Immunocytochemistry. We tested whether the EOE cells
atsecondpassagesdiﬀerentiatedintoameloblast-lineagecells
in the IGF-IGFBP-VN or Col-I dishes. EOE cells, grown for
10 days on coverslips, were ﬁxed in 4% paraformaldehyde
for 10min at room temperature and then treated with 0.1%
Triton X-100 (Sigma-Aldrich, St. Louis, MO) for 5min to
render them permeable. The cells were then incubated with
the 4% horse serum diluted in 0.01MPBS. After blocking,
the cells were incubated for 60min in aﬃnity-puriﬁed rabbit
anti-pig amelogenin polyclonal antibody (1:100 dilution;
a gift from Dr. J. P. Simmer, University of Michigan, Ann
Arbor, MI) as an ameloblast marker. FITC-conjugated goat
anti-rabbit IgG (ICN Pharmaceuticals, Inc., Aurora, OH)
was then applied for 60min at room temperature. The
stained cells were sealed with Vectashield mounting medium
containing DPAI (Dojindo) diluted 1:2000. Nonimmune
rabbit serum was used to replace primary antibody as a
ﬂuorescence control.
2.6. Preparation of Collagen Sponge Scaﬀolds. Based on our
previous results, collagen sponges were selected as scaﬀolds
for our in vivo study (product number: CL025-PH56f/
FD90H48-02F26; a gift from NIPRO Corporation, Osaka,
Japan). The performance of collagen sponge has been shown
to be superior to that of polyglycolic acid ﬁber mesh [29].
Brieﬂy, scaﬀolds approximately 10mm in diameter and
2mm in thickness were prepared from a 2.5% aqueous
solution of collagen extracted from porcine skin. They con-
tained 75% (dry weight) type I atelocollagen and 25% type
III atelocollagen and were frozen at −40◦C and vacuum-
dried to produce a porous matrix (pore volume fraction,
97.5%).
2.7. Enamel-Tissue Engineering Using a Combination of
E O EP r o g e n i t o rC e l l sa n dD e n t a lP u l pC e l l sI nV i v o .All
experiments involving the use of animals were approved
by the Institutional Animal Care and Use Committees of
the Institute of Medical Science at the University of Tokyo,
Japan.
Previously, we established a method to generate enamel
basedonacell-scaﬀoldconstructfollowedbytransplantation
in vivo. To determine whether EOE cells subcultured using
IGF-IGFBP-VN culture dishes have the potential to generate
enamel tissues, we used our transplantation experiment.
Primary dental pulp cells were obtained from impacted third
molar teeth in the mandibles of 6-month-old pigs. After
hard tissues were discarded from the tooth, only dental
pulp was disconnected from the enamel organ by treatment
with dispase II (Goudou Syuzei, Tokyo, Japan) and then the
pulp core in the center of the dental pulp was mechanically
isolated to prevent contamination of the dental follicle.
Minced pulp core was treated with collagenase (Wako) in
Hank’s balanced salt solution (Invitrogen) for 30min at
37◦C. The released cells were passed through a 70μmc e l l
strainer (Becton Dickinson & Co.).
The cell-seeding technique involving the combination of
high densities of subcultured EOE cells with high densities of
primary dental pulp cells has been described previously [30].
A high density of primary dental pulp cells (30μLo f5 . 0×
106 cells/mL) was ﬁrst placed on top of the collagen sponges
and incubated for 1h. Subsequently, a high density of EOE
cells at day 10 of cultivation (30μLo f5× 106 cells/mL)
after 1 passage was seeded directly on top of the dental pulp
cells. The subcultured EOE cells were allowed to adhere onto
the dental pulp cells for an additional hour. In the control
group, oral keratinocytes obtained from the oral mucosa
of 6-month-old pig mandibular jaws were subcultured and
seeded at high density on the top of the dental pulp cells
after the primary dental pulp cells had been seeded onto the
collagen sponges (n = 3). The scaﬀolds with cells were then
transplanted into the omentum of immunodeﬁcient rats
aged 5–7 weeks (F344/n Jcl-rnu, Nihoncrea, Japan) (n = 3).
The omentum was sutured to prevent movement of the test
and control implants [31–33]. The implants were allowed
to develop for 4 weeks after which time they were ﬁxed in
Bouin’s solution and demineralized in 30% EDTA and then
embedded in paraﬃn. 5 μm sections were cut and stained
with hematoxylin and eosin for histological analysis.
Since epithelium and pulp tissues are tightly connected,
there is a high chance of contamination. This was monitored
by observation with phase contrast microscopy and RT-PCR
using the cultivation of dental pulp cells. This conﬁrmation
has been used in our previous studies [34, 35].
2.8. Immunohistochemistry. Immunohistochemical analyses
were performed on paraﬃn-embedded tissue sections with
a Vectastain ABC kit (Vector Laboratories, Inc., Burlingame)
using aﬃnity-puriﬁed rabbit anti-pig amelogenin polyclonal
antibody (1:2000 dilution, gift from Dr Simmer, University
of Michigan, USA) as the primary antibody. Standard
procedures[36]weremodiﬁedasdescribedindetailbyChen
et al. [37].4 International Journal of Dentistry
Table 1: Sequence of primer pairs used for semiquantitative RT-PCR.
Gene Sequence Annealing temperature
(◦C)
Amplicon
(bp)
Accession number or
reference
Amelogenin Forward 5-CCTGCCTTTTGGGAGCA 50 328 NM213800
Reverse 5-TGGTGGTGTTGGGTTGGA
Ameloblastin Forward 5-ATTCCCAACCTGGCAAGAGG 55 380 NM214037
Reverse 5-AGCGCTTTTAATGCCTTTGC
Enamelin Forward 5-TGAGGAGATGATGCGCTATG 45 315 NM214241
Reverse 5-TGAGGTGTCTGGGTTTCCTC
Enamelysin Forward 5-ATACGTGCAGCGAATAGATGC 45 290 NM213905
Reverse 5-CTATTTAGCAACCAATCCAGG
Collagen type I Forward 5-GATCCTGCTGACGTGGCCAT 55 212 AY350905
Reverse 5-ACTCGTGCAGCCGTCGTAGA
IGF-I Forward 5-GACGCTCTTCAGTTCGTGTG 50 348 NM214256
Reverse 5-ACTCGTGCAGAGCAAAGGAT
IGF-IR Forward 5-ACTGTATGGTGGCCGAAGAC 50 391 NM214172
Reverse 5-ATCTCGTCCTTGATGCTGCT
beta-actin Forward 5-TCGACCACAGGGTAGGTTTC 45 497 AF017079
Reverse 5-CCCCAGCATCAAAGGTAGAA
3. Results
3.1. Eﬀect of IGF-IGFBP-VN on EOE Cell Growth. EOE cells
wereeasilyobtainedfromexplantculture,buttheculturewas
a mixed population (Figure 1(a)). After replacing the serum-
containing medium with nonserum medium, the dental
follicle cells disappeared and only the EOE cells were left.
The EOE cells showed the cobblestone morphology that is
typical of epithelial cells (Figure 1(b)). However the EOE
cells did not grow in the nonserum medium, so selected
EOE cells were then plated onto the IGF-IGFBP-VN-coated
dishes (passage 1) and after four days of subculture, several
small colonies of EOE cells appeared (Figure 1(c)). The
colonies increased with time and became conﬂuent after 25
days of cultivation and were then subcultured as passage
2( Figure 1(d)). Both groups of passaged cells showed the
typical polygonal-shaped epithelial morphology. EOE cells
were also cultured onto PS (Figure 1(d)) and Col-I-coated
dishes (passage 1) (Figure 1(e)); however, the EOE cells
displayed an extended morphology. In addition, EOE cells
could not be grown on either PS or Col-I dishes after the
second passage.
We compared the rate of cell proliferation of EOE cells
that were cultured on the IGF-IGFBP-VN, Col-I, and PS
culture dishes at passage 1 (Figure 2). We found that EOE
cells grew at similar rates on the IGF-IGFBP-VN and Col-I
culture dishes until day 10 of cultivation, but the cells exhib-
ited a much lower proliferation rate at day 25 of cultivation
when cultured on the Col-I dishes. There was a signiﬁcant
diﬀerence (P<0.05) at day 25 between the growth rates in
thesediﬀerentcultureconditions.Interestingly,EOEcellsdid
not grow on the PS dishes.
3.2. Diﬀerentiation of EOE Cells. We studied whether the
EOE cells would be able to diﬀerentiate into ameloblasts.
RT-PCR was used to examine the expression of various
ameloblast-related genes (Table 1) in the EOE cells. The EOE
cells, grown in LHC-9 as primary culture cells, expressed
mRNA for amelogenin, ameloblastin, enamelin, MMP-20,
IGF-I, IGF-I receptor (IGF-IR), and collagen type I. After
subcultureatpassage1,expressionofamelogeninandMMP-
20wasnotdetectedinthePSculturethoughsomeexpression
of ameloblastin and enamelin was detected (Figure 3). The
expressionpatternoftheameloblast-relatedgenesoftheEOE
cells in the Col-I culture was similar to that of the IGF-
IGFBP-VN culture. Interestingly, mRNA of amelogenin in
the IGF-IGFBP-VN culture was more highly expressed than
that in the Col-I culture. In addition, expression of IGF-I
and IGF-IR mRNA was higher in the IGF-IGFBP-VN culture
than that in the Col-I culture. Collagen type I gene was not
detected in any of the cultures at passage 1 (Figure 3).
Using immunocytochemistry, we next examined the
protein expression of amelogenin to determine whether the
EOE cells were diﬀerentiated into ameloblasts. Amelogenin
expression was detected in the EOE cells in both the Col-I
(Figures4(a)and4(b))andIGF-IGFBP-VNcultures(Figures
4(c), 4(d),a n d4(e)) after 14 days cultivation at passage 1.
The degree of expression in the IGF-IGFBP-VN culture was
higherthanthatoftheCol-Iculture.Therewasnoexpression
of amelogenin in the EOE cells under PS culture conditions
(data not shown).
3.3. Histology of the Tissue-Engineered Enamel-Dentin Com-
plexes. We examined the enamel-forming capability of the
EOE cells by transplanting seeded collagen sponges into the
omentum of athymic rats. These in vivo experiments were
performed 3 times for a transplantation period and obtained
consistent data at the time period examined.
At four weeks after transplantation, the implants from
the scaﬀolds seeded with both cultured EOE cells and
fresh dental pulp cells revealed hard tissue formation
(Figure 5(a)). At this time, the scaﬀolds were alreadyInternational Journal of Dentistry 5
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Figure 1: Phase-contrast micrographs. (a) Mixed culture of enamel organ-derived epithelial (EOE) cells and dental follicle cells after 1 week
of culture. The epithelial cells (e) have formed an island within the strongly proliferating dental follicle cells (df). (b) EOE cells in LHC-
9 medium. After replacing the serum-medium with LHC-9, only EOE cells survived in the nonserum medium. The colony of EOE cells
showed a cobblestone appearance associated with typical epithelial morphology. (c) Subcultured EOE cells (passage 1) grown on the insulin-
like growth factor-I/insulin-like growth factor binding protein-3/vitronectin complex after 10 days of cultivation. (d) EOE cells cultured on
insulin-like growth factor-I/insulin-like growth factor binding protein-3/vitronectin (IGF-IGFBP-VN) complex. After 1 passaged, EOE cells
hadthesamecharacteristicmorphology.After25daysofcultivation, thecolonybecameconﬂuent.TheEOEcellshadthesamecharacteristic
morphology. (e) EOE cells cultured on collagen type I-coated dishes. The cells showed a vague outline and expanded morphology. (f) EOE
cells cultured on PS. The EOE cells displayed on extended morphology. Scale bars: 100μm( a ) ,5 0μm (b–d) length.
degraded and not visible in the implants. The developmental
stage of amelogenesis was recognized in one implant at
this stage. Enamel organ-like structures and enamel-dentin
complex-like structures were recognized in the implants
from the scaﬀolds seeded with both cultured EOE cells and
fresh dental papilla cells by histological analysis (Figures 5(b)
and 5(c)). In hematoxylin-eosin stained sections, at high
magniﬁcation, enamel-like tissue was easily found inside the
dentin-like tissue generated in the implants (Figure 5(d)).
At higher magniﬁcation, the width of the dentin-like tissue
was approximately 50μm. The tall columnar ameloblast-like
cells were aligned with the surface of the thin enamel-like
tissues. The nuclei of the ameloblasts were localized at the
edge of the cells most distal to the epithelial cells. At this
stage, dentin tubules were clearly identiﬁed in the enamel-
dentin-like complex (Figure 5(e)).6 International Journal of Dentistry
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Figure 2: Comparison of the cell proliferation of enamel organ-
derived epithelial (EOE) cells on polystyrene, collagen type I,
and insulin-like growth factor-I/insulin-like growth factor binding
protein-3/vitronectin (IGF-IGFBP-VN) complex at passage 1. The
number of cells was counted on days 1, 10, and 25. The growth of
EOE cells on IGF-IGFBP-VN complex was faster than that of EOE
cells on Col-I. The EOE cells did not grow on PS. Asterisks indicate
a signiﬁcant diﬀerence (P<0.05) between paired conditions.
Immunohistochemistry was used to examine the dis-
tribution of amelogenin in the implants at 4 weeks after
transplantation. Amelogenin expression was present in
the enamel-like tissue and ameloblast-like cells, while the
ameloblast-like cells without enamel formation stained neg-
ative for amelogenin (Figure 5(f)).
4. Discussion
This study reports a new in vitro culture technique for
EOE cells using a complex of IGF-I, IGFBP-3, and VN.
We have demonstrated the potential use of this IGF-
IGFBP-VN complex in the manufacture of bioengineered
enamel through the transplantation assay of EOE cells, but
some interaction with dental mesenchymal cells is required
for enamel generation. Four weeks after transplantation,
enamel was produced on the surface of the dentin after
dentin formation. During the enamel formation process, the
presenceofcomponentsoftheenamelorgan,suchasthecells
resembling stellate reticulum, inner enamel epithelium, and
ameloblasts, appeared to mimic the course of normal enamel
development. On the other hand, after the propagation
of EOE cells in vitro,E O Ec e l l sw e r ed i ﬀerentiated into
preameloblasts or ameloblasts associated with ameloblast-
related gene and protein expressions. The characterization
of stem/progenitor cells includes the capacity for both self-
renewal and diﬀerentiation. Based on our in vitro and in vivo
research,wehavedemonstratedthatculturedEOEcellsusing
P PS CO IGF
AML
AMBL
ENAM
MMP20
COLI
IGF-I
IGF-IR
Actin
Figure 3: Semiquantitative reverse transcription-polymerase chain
reaction analysis of enamel organ-derived epithelial (EOE) cells
cultured on insulin-like growth factor-I/insulin-like growth factor
binding protein-3/vitronectin complex (IGF) in comparison with
the mixed cells from the primary culture (P), and EOE cells on
polystyrene (PS) and collagen- type-I-(Co)- coated dishes. Amel-
ogenin (AML), ameloblastin (AMBL), enamelin (ENAM), matrix
metalloprotease-20 (enamelysin, MMP20), collagen I (COLI),
insulin-like growth factor-I (IGF-I), insulin-like growth factor I
receptor (IGF-IR), and beta-actin (Actin) in cultured EOE cells
were examined. Primary cells (P) expressed all the examined genes.
Cultured EOE cells at passage 1 on PS expressed ameloblastin and
enamelin. The expression pattern in the IGF culture was similar to
that of the CO culture. Both IGF-I and IGF-IR were more strongly
expressed in IGF compared to CO.
IGF-IGFBP-VN include the cells with stem/progenitor char-
acteristics. However, further analysis is needed to examine
the precisely developmental stage of EOE cells.
Our previous approach solved the main obstacle to
propagation of EOE cells in vitro by using a feeder layer
of cells [27]. Cultured EOE cells, under a feeder layer,
in combination with dental papilla cells formed enamel-
dentin complexes in our in vivo experiments. As a control,
we examined the potential of oral keratinocytes to form
enamel by using the same methods, but there was no
enamel formation in the implants in vivo. This was the
ﬁrst report of enamel-tissue engineering using cultured EOE
cells. Although the approach of using a feeder layer has
proven to be a major advance [38, 39], the method is quite
complicated and there is the possibility that the cells in the
feeder layer may turn cancerous because immortalized 3T3-
J2cellsareusedasthefeederlayer[39].Thus,anewapproach
to propagate EOE cells without feeder cells was desirable.
Interestingly, the period required for enamel generation by
our approach using IGF-IGFBP-VN was similar to that of
using a feeder layer [34]. Since the source of the dental pulp
cells for combination with the scaﬀold is the same [34],
these results suggest that the potential of this new techniqueInternational Journal of Dentistry 7
(a) (b)
(c) (d)
(e)
Figure 4:Immunoﬂuorescenceanalysisinenamelorgan-derivedepithelial(EOE)cells.(a)ImmunoﬂuorescenceshowedthatEOEcellswere
positive for amelogenin in the collagen type I-coated dishes. (b) Merged image to (a). Amelogenin staining in combination with DAPI to
stain DNA (blue). (c) EOE cells were positive for amelogenin by immunoﬂuorescence in the insulin-like growth factor-I/insulin-like growth
factor binding protein-3/vitronectin complex-coated dishes. The staining of amelogenin in the EOE cells was more intense than that in the
collagen type I-coated dishes. (d) Merged image to (c). Amelogenin staining in combination with DAPI to stain DNA (blue). Scale bars:
50μm length (a–d). (e) The high magniﬁcation view of (d). EOE cells cultured on in the insulin-like growth factor-I/insulin-like growth
factor binding protein-3/vitronectin complex-coated dishes expressed strongly amelogenin.
using the IGF-IGFBP-VN complex is similar to that of the
technique using a feeder layer of cells.
How does the IGF-IGFBP-VN complex work in the EOE
cells? Although our results indicated that IGF-I and IGF
receptor expression was observed in the EOE cells in all
culture conditions, interestingly, the EOE cells in the IGF-
IGFBP-VN culture dishes highly expressed IGF-I and the
IGF-I receptor, which indicated that the activity could be
increased by autocrine or paracrine signals. Little is known
about the eﬀects of VN on EOE cells although an increasing
number of functions are being discovered for VN. The
molecule is best known for its actions on cell attachment
and spreading [16, 40]. In a study of epithelial cells, it
was demonstrated that VN has an eﬀect on the metabolic
activity of cultured corneal-limbal epithelial cells [23]a n d
skin keratinocytes [28]. It is therefore not surprising that the
cellular activity of EOE cells was enhanced by VN.
It is well known that IGF-I is a potent mitogen involved
in normal growth and development [1] and inﬂuences cell
divisionanddiﬀerentiation[41,42].IGFsarealsorecognized
as having important roles in tooth development; addition
of exogenous IGF-I to molar teeth maintained in culture8 International Journal of Dentistry
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Figure 5: The implants at four weeks after transplantation. (a) Round-shaped implants were produced by the constructs formed between
cultured enamel organ-derived epithelial (EOE) cells and dental pulp cells in a scaﬀold. (b) An enamel organ-like structure associated with
an epithelial cell cluster was seen in the implant. Columnar cells were organized in a circle and dental pulp cells embraced the enamel organ.
(c) Enamel-like tissue formation on the surface of the dentin, stained with hematoxylin-eosin. (d) High magniﬁcation of (c), showing that
enamel-like tissue (black arrow) stained with eosin was strongly displayed in the implant. (e) High magniﬁcation of (c), showing that tall
columnar ameloblast-like cells (am) were aligned perpendicular to the dentin-like tissues (d). (f) High magniﬁcation of (c), showing that
amelogenin expression was strongly identiﬁed in the enamel-like tissue adjacent to the dentin-like tissues and ameloblast-like cells. Scale
bars: 50μm (b, d–f), 200μm (c) length.
results in an increase in tooth volume [43]. In organ
cultures of mouse molars, exogenous administration of IGF-
I increases the synthesis of amelogenin, ameloblastin, and
enamelin [44]. These results suggest that IGF-I promotes
diﬀerentiation and development of ameloblasts. The IGF-
I receptor has also been identiﬁed in the enamel organ
across amelogenesis [8]. Moreover, IGF-I appears to be
eﬀective in promoting proliferation of Hertwig’s epithelial
root sheath [10]. Thus, IGF and its receptors are involved
in the growth of the epithelium as the tooth develops,
including the stages of crown and root formation. In our
study, the expression of IGF-I was dramatically increased
in EOE cells in culture with the IGF-IGFBP-VN complex.
The signiﬁcance of the IGF-IGFBP-VN complex has been
conﬁrmed through observation of other cellular responses
in culture plates pretreated with VN, IGF-I, and IGFBP-3
[21, 22]. This is the ﬁrst study to demonstrate that the IGF-
IGFBP-VN complex can enhance the proliferation activityInternational Journal of Dentistry 9
associated with the maintenance of the phenotype of EOE
cells. Although IGF-IGFBP-VN plays critical functions in the
cell cycle, the exact mechanism by which IGF-IGFBP-VN
facilitates cell proliferation remains unclear. Recently, there
is accumulating evidence for direct cooperation between
the IGF-I receptor and αv-integrins as the signaling path-
ways between these receptors are clearly interconnected
[45, 46]. Furthermore, IGF-I-IGFBP-VN complexes induce
synergistic increases in intracellular signal transduction, in
particular, an increased and sustained activation of the
phosphatidylinositol 3-kinase/AKT pathway [25]. Through
the IGF-I receptor, IGF-I can activate multiple signaling
pathways, including the phosphatidylinositol 3-kinase and
mitogen-activated protein kinase pathways in tumor cells
[47]. Facilitation of the cell cycles may accelerate tissue
development, however further studies will be required to
clarify this issue.
To develop a protocol for enamel-tissue engineering,
an appropriate culture method is required to obtain a
suﬃcientnumberofstem/progenitorcells.Thepresentstudy
revealed that the IGF-IGFBP-VN complex provides a viable
alternative to the feeder layer technique. Nevertheless, there
isroomforreﬁnementofthistechnology,includingextended
serial propagation studies, the use of alternative markers of
diﬀerentiated ameloblasts and formed enamel, and further
optimization of the IGF-IGFBP-VN complex formulation to
increase the formation of enamel.
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